Author: Ryan Gregory - Page 3

Irritable Bowel Syndrome: Symptoms, Triggers, and Medication Options
Dec 1 2025 Ryan Gregory

Irritable Bowel Syndrome: Symptoms, Triggers, and Medication Options

Irritable Bowel Syndrome causes abdominal pain, bloating, and unpredictable bowel changes. Learn the key symptoms, common triggers like FODMAPs and stress, and proven medication options for IBS-D, IBS-C, and mixed types.

Detail
Anticoagulants: Warfarin vs DOACs - Safety, Risks, and What You Need to Know
Dec 1 2025 Ryan Gregory

Anticoagulants: Warfarin vs DOACs - Safety, Risks, and What You Need to Know

Warfarin and DOACs both prevent dangerous clots, but DOACs are safer and easier to use for most people. Learn the real differences in bleeding risk, kidney safety, cost, and adherence - and what to ask your doctor.

Detail
Anticonvulsants and Birth Control: What You Need to Know About Reduced Effectiveness
Nov 30 2025 Ryan Gregory

Anticonvulsants and Birth Control: What You Need to Know About Reduced Effectiveness

Many anticonvulsants like carbamazepine and topiramate reduce birth control effectiveness by speeding up hormone metabolism. This can lead to unintended pregnancy. Learn which seizure meds interfere, which contraceptives still work, and what to do next.

Detail
How to Verify Controlled Substance Quantities and Directions: A Step-by-Step Guide for Pharmacists
Nov 28 2025 Ryan Gregory

How to Verify Controlled Substance Quantities and Directions: A Step-by-Step Guide for Pharmacists

Learn the exact steps pharmacists must follow to verify controlled substance quantities and directions to avoid legal penalties, prevent diversion, and ensure patient safety. Includes DEA math, PDMP checks, CDC conversion factors, and real-world pitfalls.

Detail
How to Read Medication Guides to Understand Risk and Monitoring Requirements
Nov 26 2025 Ryan Gregory

How to Read Medication Guides to Understand Risk and Monitoring Requirements

Learn how to read FDA-required Medication Guides to spot serious drug risks and follow critical monitoring steps. Understand what to look for, how to act, and why skipping this guide could be dangerous.

Detail
Compounding Pharmacies: What to Do When Your Medication Isn't Available
Nov 25 2025 Ryan Gregory

Compounding Pharmacies: What to Do When Your Medication Isn't Available

When your medication runs out and isn't coming back, compounding pharmacies offer customized alternatives tailored to your needs-no allergens, perfect doses, or easier forms. Here's how they work and when to use them.

Detail
FDA Inspection of Generic Manufacturing Facilities: What to Expect in 2025
Nov 20 2025 Ryan Gregory

FDA Inspection of Generic Manufacturing Facilities: What to Expect in 2025

Understand what happens during an FDA inspection of a generic drug manufacturing facility, including the six-system review, Pre-Approval Inspections, FDA 483 observations, and how to prepare for compliance in 2025.

Detail
Hepatocellular Carcinoma Surveillance and Treatment in Cirrhosis: What You Need to Know
Nov 19 2025 Ryan Gregory

Hepatocellular Carcinoma Surveillance and Treatment in Cirrhosis: What You Need to Know

Hepatocellular carcinoma is the most common liver cancer, mostly affecting people with cirrhosis. Regular 6-month ultrasounds can catch it early, when cure is still possible. Learn who needs screening, how it works, and what treatments are available today.

Detail
Insulin Allergies: How to Spot and Handle Injection Reactions
Nov 18 2025 Ryan Gregory

Insulin Allergies: How to Spot and Handle Injection Reactions

Insulin allergies are rare but serious. Learn how to recognize injection reactions-local, systemic, or delayed-and what to do next, from antihistamines to desensitization, without stopping life-saving insulin therapy.

Detail
The 80-125% Rule: Understanding Bioequivalence Confidence Intervals in Generic Drugs
Nov 17 2025 Ryan Gregory

The 80-125% Rule: Understanding Bioequivalence Confidence Intervals in Generic Drugs

The 80-125% rule ensures generic drugs are absorbed similarly to brand-name versions. It's based on pharmacokinetic data, not active ingredient amounts, and is used globally to approve safe, affordable generics.

Detail